BioTime (Warrant)

YTD

ALL

Why Robinhood?

You can watch BTX+ and buy or sell other stocks, ETFs, and their options commission-free!

About BTX+

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.

CEO

Brian M. Culley, MBA

CEOBrian M. Culley, MBA

Employees

—

Employees—

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

1990

Founded1990

Employees

—

Employees—

BTX+ Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Stock Snapshot

BioTime (Warrant)(BTX+) trades at $0.01.

On 2025-12-04, BioTime (Warrant)(BTX+) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0.